Hematologist
CION Cancer Clinics
Rituximab alone or with chemotherapy for follicular lymphoma? | CION Cancer Clinics
Rituximab alone is the gentler choice and often suits a smaller amount of lymphoma, or someone older or less fit. Rituximab with chemotherapy usually shrinks follicular lymphoma more deeply and keeps it away longer, but brings more tiredness, infections and low blood counts. Neither is right for everyone. This page compares them, says who each does not suit, and lists what to ask your haematologist. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Should follicular lymphoma be treated with rituximab alone or with chemotherapy?
- How do the two approaches compare?
- Who does each option tend to suit, and who not?
- What happens before either treatment starts?
- What do families often believe about this choice?
- What should you ask before deciding?
- Common questions about rituximab alone versus chemotherapy
The short answer
Should follicular lymphoma be treated with rituximab alone or with chemotherapy?
Rituximab alone is gentler and often suits people with a smaller amount of lymphoma, or who are older or less fit. Rituximab with chemotherapy usually shrinks the lymphoma more deeply and keeps it away for longer, at the cost of more side effects.
What each option is
Rituximab is an antibody, a protein made in a laboratory, that sticks to a marker called CD20 on lymphoma cells and helps the immune system clear them. Chemoimmunotherapy means rituximab given together with chemotherapy drugs. Common combinations are bendamustine with rituximab, R-CHOP and R-CVP. Some newer plans use a related antibody called obinutuzumab instead.
Why both are reasonable choices
Follicular lymphoma usually returns at some point, whichever treatment is used first. So the question is not only how deep the first response is. It is also how much treatment you want to carry now, and what you keep in reserve for later. For many people, neither choice is clearly right or wrong.
What decides it for most people
The amount of lymphoma, how fast it is causing trouble, the grade, your age and fitness, other illnesses such as heart or lung disease, and what you want from treatment. Your haematologist weighs these with you.
Side by side
How do the two approaches compare?
Rituximab alone
Rituximab with chemotherapy
A short course of drips, sometimes followed by a few more spaced out
Several cycles over some months, each with more than one drug
Hair loss is not expected, and sickness is uncommon
Tiredness, sickness and low blood counts are more common
Response is often partial and may last a shorter time
Response is usually deeper and tends to last longer
Lower infection risk
Higher infection risk, sometimes for months after treatment ends
Keeps chemotherapy in reserve for later
Uses a stronger option first
Fitting the person
Who does each option tend to suit, and who not?
These are patterns, not rules. Your own team may advise differently for good reasons.
Rituximab alone often suits
People with a small amount of lymphoma that needs treatment, or who are older, frailer or have other illnesses that make chemotherapy risky. It also suits people who want to avoid chemotherapy side effects for now.
Less suited to
- Large, bulky masses
- Lymphoma pressing on organs
- Grade 3B or changed lymphoma
Chemoimmunotherapy often suits
Fitter people with a larger amount of lymphoma, symptoms, or organs under pressure, where a deep and lasting response matters most.
Less suited to
- Serious heart, lung or kidney disease
- Active infections that are not controlled
- People who cannot reach day-care for each cycle
Radiotherapy instead
If the lymphoma is limited to one or two nearby areas, low-dose radiotherapy alone may be offered in place of either drug option.
Ask whether your stage makes this possible.Not sure whether this applies to you?
Ask an oncologistBefore the first drip
What happens before either treatment starts?
Hepatitis B test
Rituximab can wake up a hidden hepatitis B infection. A blood test is done first, and if it is positive, your team plans how to protect the liver.
Heart and kidney checks
Before some chemotherapy drugs, a heart scan and kidney tests are done. These help choose a combination that is safe for you.
Vaccines and infections
Your team reviews vaccines and any infections such as tuberculosis before treatment lowers your defences.
Planning the schedule
You get a written plan of drip days, blood tests and review dates, and a number to call if you feel unwell at home.
Commonly believed
What do families often believe about this choice?
"Rituximab alone is the weak option we choose if we cannot afford more."
It is a proper, evidence-based treatment used worldwide, including where money is no barrier. For the right person it is the sensible first step. Cost should be discussed openly, but it is not the reason it exists.
"Stronger treatment first means it will not come back."
A deeper response usually lasts longer, but follicular lymphoma often returns in time whichever option is used. That is why the choice also weighs side effects and what is kept for later.
"Rituximab has no real side effects."
It is gentler, but the first drip often causes a reaction: chills, fever, rash or breathlessness. Nurses give it slowly and watch closely. It can also lower antibodies and raise infection risk over time.
"Once you choose one, you cannot change."
If rituximab alone does not work well enough, or the lymphoma returns, chemoimmunotherapy is still possible later. Choices are revisited at each step.
Did you know
Rituximab can also be given as an injection under the skin after the first dose, which takes much less time in day-care than a drip. Ask your team whether this form is available and suitable for you.
Being straight with you
What should you ask before deciding?
Ask why the team is recommending one option for you, and what would make them suggest the other. Ask what side effects to expect, how many day-care visits are involved, and whether maintenance rituximab would follow.
Questions families often forget
How will this affect work or caring for children? What is the infection risk, and what should we do about a fever at home? What treatment would be used if the lymphoma returns? Is radiotherapy an option for my stage?
What this page cannot tell you
It cannot choose for you, and it cannot tell you how long either treatment will keep the lymphoma away in your case. Studies describe groups, not individuals. At CION, the haematology team reviews your biopsy, scans and blood tests, discusses the case at a tumour board, and explains the reasons behind the recommendation.
Never stop or skip a planned drip on your own. Talk to your team first.Questions we are asked
Common questions about rituximab alone versus chemotherapy
Is rituximab a type of chemotherapy?
No. Rituximab is an antibody treatment, sometimes grouped with immunotherapy or targeted therapy. It works by marking lymphoma cells for the immune system rather than poisoning dividing cells. It is often given alongside chemotherapy, which is why families sometimes mix the two up.
Will I lose my hair?
Not with rituximab alone. With chemoimmunotherapy it depends on the drugs. Bendamustine with rituximab usually causes little hair thinning. R-CHOP usually causes hair loss, which grows back after treatment ends. Ask which combination you are being offered.
Which option lets me keep working?
Many people keep working through rituximab alone, taking the drip days off. Chemoimmunotherapy is more tiring, and some people reduce hours for a few months. Tell your team about your work and travel early, because schedules can sometimes be arranged around them.
What happens if rituximab alone does not work?
Your team reviews the lymphoma again, sometimes with a new scan or biopsy. Chemoimmunotherapy or another treatment can then be offered. Trying the gentler option first does not usually close off stronger choices later.
Why is a hepatitis B test needed?
Many people carry a quiet hepatitis B infection without knowing. Rituximab can let it flare and damage the liver. A simple blood test before treatment finds it, and your team then plans protection. Do not skip this test, even if you had it done years ago.
Is one option much more expensive?
Costs depend on the drugs, the number of cycles and whether a biosimilar, a close copy of the original medicine, is used. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover much of it. Rules change, so check the current rules. The helpline can give an estimate against your cover.
Can an older parent have chemoimmunotherapy?
Age alone does not rule it out. Fitness, other illnesses and support at home matter more. Some older people manage it well, while others are better served by rituximab alone. Your haematologist can assess fitness and explain the choice to the whole family.
What should we do about a fever during treatment?
Treat any fever during chemoimmunotherapy as urgent. Call your treating team straight away, and if you cannot reach them, go to the nearest emergency department or call 108. Say which treatment the person is on. Do not wait until the morning.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer Research UK — Follicular lymphoma
- National Cancer Institute — Rituximab
- NICE — Rituximab for the first-line treatment of stage III-IV follicular lymphoma (TA243)
- American Cancer Society — Non-Hodgkin Lymphoma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Weighing up treatment options?
Tell us what has been found so far. Our haematology team will review the reports and help you reach the right specialist.